Global Dermatology Partnering Directory 2018: Deal Trends, Players and Financials Since 2012

Dublin, March 15, 2018 -- The "Global Dermatology Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

The Global Dermatology Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2012-2018 includes:

• Trends in dermatology dealmaking in the biopharma industry since 2012
• Analysis of dermatology deal structure
• Access to headline, upfront, milestone and royalty data
• Access to over 700 dermatology deal records
• The leading dermatology deals by value since 2012

The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2012-2018, the available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking

2.1. Introduction
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication

Chapter 3 - Financial deal terms for Dermatology partnering

3.1. Introduction
3.2. Disclosed financials terms for Dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers

4.1. Introduction
4.2. Most active in Dermatology partnering
4.3. List of most active dealmakers in Dermatology
4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory

5.1. Introduction
5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Dermatology therapeutic target

Appendices

Appendix 1 - Directory of Dermatology deals by company A-Z 2012 to 2018
Appendix 2 - Directory of Dermatology deals by deal type 2012 to 2018
Appendix 3 - Directory of Dermatology deals by stage of development 2012 to 2018
Appendix 4 - Directory of Dermatology deals by technology type 2012 to 2018

For more information about this report visit https://www.researchandmarkets.com/research/9mlpnd/global?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Dermatological Drugs